Stockscreener 앱 받기
1.22
10.29%
-0.14
전일 마감가:
$1.36
열려 있는:
$1.26
하루 거래량:
103.78K
Relative Volume:
1.55
시가총액:
$66.71M
수익:
$118.18M
순이익/손실:
$5.99M
주가수익비율:
9.2494
EPS:
0.1319
순현금흐름:
$-12.91M
1주 성능:
-12.86%
1개월 성능:
-6.94%
6개월 성능:
-19.74%
1년 성능:
-18.12%
1일 변동 폭
$1.22
$1.27
1주일 범위
$1.22
$1.5098
52주 변동 폭
$1.22
$1.79
Intercure Ltd Stock (INCR) Company Profile
INCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.22 | 74.37M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
123.10 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 47.07B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.965 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.99 | 34.82B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
512.91 | 22.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-18 | 업그레이드 | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd 주식(INCR)의 최신 뉴스
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
Why InterCure Ltd. stock could see breakout soonGDP Growth & Weekly High Momentum Picks - Улправда
Will InterCure Ltd. stock gain from strong economyJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - ulpravda.ru
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Why InterCure Ltd. stock appeals to dividend seekersTrade Exit Summary & Verified Entry Point Signals - Newser
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com Nigeria
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv By Investing.com - Investing.com South Africa
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Why InterCure Ltd. stock remains undervaluedJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
How InterCure Ltd. stock performs in weak economyMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Can InterCure Ltd. stock beat market expectations this quarterJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Is it time to cut losses on InterCure Ltd.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Is InterCure Ltd. stock a buy in volatile marketsIndex Update & Advanced Swing Trade Entry Plans - newser.com
How strong is InterCure Ltd. stock revenue growthJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Is InterCure Ltd. stock cheap at current valuationJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Will InterCure Ltd. stock recover after recent dropWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Does InterCure Ltd. stock trade at a discount to peersLayoff News & Long-Term Growth Stock Strategies - newser.com
Will InterCure Ltd. stock sustain high P E ratiosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
Will InterCure Ltd. stock outperform international peersJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Will InterCure Ltd. price bounce be sustainableInflation Watch & AI Forecasted Stock Moves - newser.com
What drives InterCure Ltd stock priceMarket Sentiment Extremes & Low Entry Capital Stocks - earlytimes.in
Will InterCure Ltd. stock benefit from green energy trendsJuly 2025 Outlook & Consistent Profit Alerts - newser.com
What insider trading reveals about InterCure Ltd. stockJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Intercure Ltd (INCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
0.54%
자본화:
|
볼륨(24시간):